Researchers have found that antiviral therapy may be successful in preventing hepatitis B virus from developing into the most common form of liver cancer, hepatocellular carcinoma (HCC). That was the finding of a study published in a recent issue of Clinical Gastroenterology and Hepatology. Overall, 3% of patients developed HCC during the study’s timeframe.

READ FULL ARTICLE Curated publisher From Medical News Today